Prostate Cancer - Results from #22660

Integration of drug treatment in the management concept of prostate cancer - Abstract September 9, 2013

Recent advances revolutionize treatment of metastatic prostate cancer - Abstract September 9, 2013

Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: Possible influence of androgen deprivation therapy - Abstract September 9, 2013

Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men - Abstract September 6, 2013

Detection of prostate cancer in peripheral zone: Comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T - Abstract September 6, 2013

You know I've joined your club… I'm the hot flush boy': A qualitative exploration of hot flushes and night sweats in men undergoing androgen deprivation therapy for prostate cancer - Abstract September 6, 2013

Use of prostate-specific antigen testing as a disease surveillance tool following radical prostatectomy - Abstract September 6, 2013

Health care costs for state transition models in prostate cancer - Abstract September 6, 2013

Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: A meta-analysis - Abstract September 6, 2013

Quality of life after sipuleucel-T therapy: Results from a randomized, double-blind study in patients with androgen-dependent prostate cancer - Abstract September 6, 2013

High-intensity focussed ultrasound in low-risk prostate cancer - Oncological outcome and postinterventional quality of life of an inexperienced therapy centre in comparison with an experienced therapy centre - Abstract September 6, 2013

Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factors - Abstract September 6, 2013

A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml - Abstract September 6, 2013

The Study of Active Monitoring in Sweden (SAMS): A randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer - Abstract September 6, 2013

Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: A 15-year study in two large US health systems - Abstract September 6, 2013

Impact of age on clinical presentation, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate - Abstract September 5, 2013

Fifteen-year mortality after radical prostatectomy: Which factors are available for patient counselling? - Abstract September 5, 2013

Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer - Abstract September 5, 2013

MRI-guided biopsy of the prostate: Correlation between the cancer detection rate and the number of previous negative TRUS biopsies - Abstract September 5, 2013

Value of intermittent androgen deprivation in the context of the current data situation - Abstract September 5, 2013

Page 1134 of 1452